Clinical, laboratory, and temporal predictors of neutralizing antibodies to SARS-CoV-2 after COVID-19

Background: SARS-CoV-2-specific antibodies may protect from reinfection and disease, providing the rationale for administration of plasma containing SARS-CoV-2 neutralizing antibodies (nAb) as a treatment for COVID-19. The clinical factors and laboratory assays to streamline plasma donor selection,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:medRxiv
Main Authors: Boonyaratanakornkit, Jim, Morishima, Chihiro, Selke, Stacy, Zamora, Danniel, McGuffin, Sarah, Shapiro, Adrienne E, Campbell, Victoria L, McClurkan, Christopher L, Jing, Lichen, Gross, Robin, Liang, Janie, Postnikova, Elena, Mazur, Steven, Chaudhary, Anu, Das, Marie K, Fink, Susan L, Bryan, Andrew, Greninger, Alex L, Jerome, Keith R, Holbrook, Michael R, Gernsheimer, Terry B, Wener, Mark H, Wald, Anna, Koelle, David M
Formato: Artigo
Idioma:Inglês
Publicado em: Cold Spring Harbor Laboratory 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7553186/
https://ncbi.nlm.nih.gov/pubmed/33052361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.10.06.20207472
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados